NFL’s Handling of Jalen Hurts’ Blood Clot Situation

The NFL recently addressed concerns regarding the Philadelphia Eagles’ management of quarterback Jalen Hurts’ blood clots during its fall league meeting. Officials expressed satisfaction with Hurts’ care and criticized erroneous reports about the incident.

Affiliate links may be included for legal sports betting partners. FOX News may receive compensation for sign-ups or wagers. Content is created independently from the FOX newsroom.

The NFL Players Association (NFLPA) released a statement disputing the league’s conclusions. Accusing the league of forming opinions without reviewing Hurts’ medical care, the union highlighted they were informed no such review would occur.

Dr. Allen Sills, NFL’s chief medical officer, vouched for the Eagles’ medical staff, describing their conservative, patient-focused approach. Sills noted the league’s historical incidence of deep vein thrombosis among players, including Hurts, remains low.

Sills reassured that all cases undergo scrutiny using advanced imaging, especially in Hurts’ situation. Such diligence ensures conditions unlikely diagnosed in non-athletes get the necessary attention.

Jeff Miller, NFL executive vice president of communications, detailed the league’s validation process involving Eagles staff and independent medical professionals. The NFL ensured comprehensive understanding of the events surrounding Hurts’ care.

Contrasting this defense, the NFLPA called for a complete investigation, emphasizing fact-finding is crucial for optimal player care and protection. Their statement criticized the NFL’s speculative conclusions without a formal review.

The discord between the NFL and NFLPA over the handling raises questions about transparency and player safety standards. A full investigation could clarify the league’s confidence versus the union’s concerns.